Dr. Firas M. Rahhal, MD

Dr. Rahhal practices at Retina-Vitreous Associates Medical Group in Los Angeles, California.

Dr. Rahhal's NPI, 1881658615, was assigned on April 17, 2006. Dr. Rahhal graduated from Uconn School Of Medicine in 1990. Dr. Rahhal's California license number on file is G78656.

Dr. Rahhal's primary practice is Retina-Vitreous Associates Medical Group, at 1245 W Wilshire Blvd, Los Angeles, CA 90017 in Los Angeles County. The practice phone is (213) 483-8810.

Dr. Rahhal's primary practice is Retina-Vitreous Associates Medical Group in Los Angeles, California. Dr. Rahhal is also affiliated with PIH Health Good Samaritan Hospital. Dmand AI also links Dr. Rahhal to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rahhal practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rahhal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rahhal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rahhal's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Rahhal treats.

CMS data shows 23,837 Medicare services from Dr. Rahhal across 19 procedure codes in 2024, for 1,210 Medicare patients. Medicare paid $1,769,667 for them. Every service was in an office.

CMS counts 1,210 Medicare patients who saw Dr. Rahhal in 2024. The largest group is 65 to 74, with 487 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rahhal's median patient age at 65, with 52% women.

In 2024, Dr. Rahhal wrote 2,052 Medicare Part D claims for 495 patients. 66% of them were for generic drugs. CMS names the drug for 1,981 of them, across 29 drugs with 11 or more claims each, at $168,577 in total drug cost. In 2023, CMS named 2,025 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rahhal for performance year 2024, reported as part of a group. Dr. Rahhal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Rahhal. Dr. Rahhal's most frequent co-authors are Robert Logan Avery, MD, Mark S. Humayun, MD and Hani Salehi-Had, MD.

Dmand AI links Dr. Rahhal to 3 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Geographic Atrophy, Retinal Vein Occlusion and Macular Degeneration.

CMS Open Payments shows 306 general payments to Dr. Rahhal from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Beaver-Visitec International, Inc. paid the most, $112,358.

Dmand AI lists 3 awards for Dr. Rahhal.

Dr. Rahhal graduated from Uconn School Of Medicine in 1990. Dr. Rahhal is a member of AAO.

Dr. Rahhal is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.